{"entity":{"id":"nct03464305","kind":"trial","name":"ASPIRIN Trial Belgium","aka":["ASPIRIN"],"tldr":"A phase 3 trial of aspirin in colorectal cancer, run by University Hospital, Antwerp, active but no longer recruiting.","summary":"ASPIRIN Trial Belgium is a phase 3, randomised interventional study registered as NCT03464305 by University Hospital, Antwerp, with a registry enrolment figure of 148 participants, started 2018-02-22 and due to reach its primary completion in 2027-12-31. Interventions recorded: acetylsalicylic acid; Placebo. Conditions listed: Colon Cancer. Primary outcome: 5 year overall survival. Colorectal eligibility wording from the registry: \"* Patients 45 years and older with histologically confirmed adenocarcinoma of the colon\". Sites: Belgium. No results are recorded here; the registry entry is the source.","status":"active","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT03464305","url":"https://clinicaltrials.gov/study/NCT03464305"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["colon-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["aspirin"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03464305","phase":"3","setting":"A Phase III Double-blind Placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients","sponsor":"University Hospital, Antwerp","enrolled":148,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03464305/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"}],"drug":[{"id":"aspirin","kind":"drug","name":"Aspirin","route":"/drugs/aspirin/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}